首页 > 最新文献

Jurnal Penyakit Dalam Indonesia最新文献

英文 中文
Efektivitas Terapi Akupunktur terhadap Penurunan Intensitas Nyeri pada Pasien dengan Nyeri Kanker 针灸治疗降低癌症患者疼痛强度的有效性
Pub Date : 2022-10-01 DOI: 10.7454/jpdi.v9i3.797
Hanna Lianti Afladhia, Rahmat Cahyanur, Sri Wahdini, Andhika Rachman
Latar Belakang: Nyeri merupakan salah satu keluhan paling banyak serta mengganggu kualitas hidup pasien kanker. Beberapa penelitian merekomendasikan intervensi multimodal yang mengkombinasikan antara terapi farmakologis dan nonfarmakologis. Salah satu pilihan tatalaksana nonfarmakologis yang dapat dipertimbangkan adalah terapi akupunktur.Tujuan: Tinjauan kasus berbasis bukti ini disusun untuk mengkaji efektivitas terapi akupunktur terhadap penurunan intensitas nyeri pada pasien dengan nyeri kanker.Metode: Pencarian dilakukan di tiga database (PubMed, Scopus, dan Embase). Kata kunci yang digunakan adalah cancer pain, malignant pain, acupuncture, acupuncture therapy, pain intensity, pain assessment, pain scale. Telaah kritis dilakukan dengan menggunakan panduan dari University of Oxford Centre for Evidence-based Medicine.Hasil: Diperoleh 4 artikel yang relevan dengan pertanyaan klinis. Terapi akupuntur secara konsisten menunjukkan penurunan intensitas nyeri, waktu onset nyeri yang lebih pendek, penurunan dosis dan jumlah analgesik yang dikonsumsi, serta kualitas hidup yang lebih baik dengan efek samping yang minimal, dibandingkan dengan terapi obat saja.Kesimpulan: Terapi akupunktur dapat dipertimbangkan sebagai terapi komplementer dalam penatalaksanaan nyeri kanker, namun tidak untuk menggantikan protokol standar nyeri. Keputusan klinis dalam menerapkan terapi akupunktur pada pasien perlu menilai preferensi pasien, aksesibilitas, serta efektivitas biaya.Kata Kunci: akupunktur, nyeri kanker, intensitas nyeri
背景:奈瑞氏病是癌症患者最常抱怨和损害其生活质量的疾病之一。一些研究建议将药物和非药物疗法相结合的多模式干预措施。可以考虑的非药物选择之一是针灸治疗。目的:本循证案例研究旨在研究针灸治疗减轻癌症患者疼痛强度的疗效。方法:在PubMed、Scopus和Embase三个数据库中进行检索。关键词是癌症疼痛、恶性疼痛、针灸、针灸疗法、疼痛强度、疼痛评估、疼痛量表。根据牛津大学循证医学中心的指导进行了批评。结果:获得了4篇与临床问题相关的文章。与单独药物治疗相比,急性针灸治疗始终显示出疼痛强度降低、起效时间缩短、剂量减少和镇痛剂用量减少,以及生活质量提高,副作用最小。结论:针灸治疗可作为癌症疼痛的辅助治疗,但不能取代标准的疼痛方案。将针灸疗法应用于患者的临床决策应评估患者的偏好、可及性和成本效益。关键词:针灸,癌症疼痛,疼痛强度
{"title":"Efektivitas Terapi Akupunktur terhadap Penurunan Intensitas Nyeri pada Pasien dengan Nyeri Kanker","authors":"Hanna Lianti Afladhia, Rahmat Cahyanur, Sri Wahdini, Andhika Rachman","doi":"10.7454/jpdi.v9i3.797","DOIUrl":"https://doi.org/10.7454/jpdi.v9i3.797","url":null,"abstract":"Latar Belakang: Nyeri merupakan salah satu keluhan paling banyak serta mengganggu kualitas hidup pasien kanker. Beberapa penelitian merekomendasikan intervensi multimodal yang mengkombinasikan antara terapi farmakologis dan nonfarmakologis. Salah satu pilihan tatalaksana nonfarmakologis yang dapat dipertimbangkan adalah terapi akupunktur.Tujuan: Tinjauan kasus berbasis bukti ini disusun untuk mengkaji efektivitas terapi akupunktur terhadap penurunan intensitas nyeri pada pasien dengan nyeri kanker.Metode: Pencarian dilakukan di tiga database (PubMed, Scopus, dan Embase). Kata kunci yang digunakan adalah cancer pain, malignant pain, acupuncture, acupuncture therapy, pain intensity, pain assessment, pain scale. Telaah kritis dilakukan dengan menggunakan panduan dari University of Oxford Centre for Evidence-based Medicine.Hasil: Diperoleh 4 artikel yang relevan dengan pertanyaan klinis. Terapi akupuntur secara konsisten menunjukkan penurunan intensitas nyeri, waktu onset nyeri yang lebih pendek, penurunan dosis dan jumlah analgesik yang dikonsumsi, serta kualitas hidup yang lebih baik dengan efek samping yang minimal, dibandingkan dengan terapi obat saja.Kesimpulan: Terapi akupunktur dapat dipertimbangkan sebagai terapi komplementer dalam penatalaksanaan nyeri kanker, namun tidak untuk menggantikan protokol standar nyeri. Keputusan klinis dalam menerapkan terapi akupunktur pada pasien perlu menilai preferensi pasien, aksesibilitas, serta efektivitas biaya.Kata Kunci: akupunktur, nyeri kanker, intensitas nyeri","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41555015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hubungan antara Stres Selama Pandemi COVID-19 dengan Kejadian Sindrom Dispepsia pada Mahasiswa Kedokteran Tahun Pertama 新冠肺炎疫情期间压力与高一医学生消化不良综合征发生的关系
Pub Date : 2022-10-01 DOI: 10.7454/jpdi.v9i3.684
W. Rahmi, Yulistini Yulistini, Arina Widya Murni
{"title":"Hubungan antara Stres Selama Pandemi COVID-19 dengan Kejadian Sindrom Dispepsia pada Mahasiswa Kedokteran Tahun Pertama","authors":"W. Rahmi, Yulistini Yulistini, Arina Widya Murni","doi":"10.7454/jpdi.v9i3.684","DOIUrl":"https://doi.org/10.7454/jpdi.v9i3.684","url":null,"abstract":"","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41532960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ancaman Reinfeksi COVID-19: Tinjauan dari Bukti Pustaka 新冠肺炎再感染威胁:排除在图书馆证据之外
Pub Date : 2022-10-01 DOI: 10.7454/jpdi.v9i3.539
M. Adnan, Ana Fauziyati
Case of COVID-19 reinfection are related to immune factors in patients who have recovered by the natural course of the infecting pathogen. However, the chance of COVID-19 reinfection are still not well established. This review aimed to discuss about reinfection-related studies, including causes and clinical manifestations, and reinfection management. Reinfection happens when a patient is infected by the SARS-CoV-2 virus, which has a different genome from previous infection. Although the comparison of clinical manifestation between reinfection and the previous infection is not clear, it is believed that vulnerable populations may have worse outcomes. Vaccination is the main option to reduce the severity of reinfection. Further studies are needed to understand the mechanisms and management of COVID-19 reinfection. Thus, the development of COVID-19 treatment and vaccine can be more effective .
COVID-19再感染病例与经病原体自然病程恢复的患者的免疫因素有关。然而,COVID-19再感染的可能性仍然不确定。本文旨在讨论再感染相关的研究,包括再感染的原因和临床表现,以及再感染的处理。当患者感染了SARS-CoV-2病毒时,就会发生再感染,这种病毒的基因组与以前的感染不同。虽然再感染与既往感染的临床表现比较尚不清楚,但认为易感人群的预后可能更差。疫苗接种是减少再感染严重程度的主要选择。需要进一步的研究来了解COVID-19再感染的机制和管理。因此,COVID-19治疗和疫苗的开发可以更有效。
{"title":"Ancaman Reinfeksi COVID-19: Tinjauan dari Bukti Pustaka","authors":"M. Adnan, Ana Fauziyati","doi":"10.7454/jpdi.v9i3.539","DOIUrl":"https://doi.org/10.7454/jpdi.v9i3.539","url":null,"abstract":"Case of COVID-19 reinfection are related to immune factors in patients who have recovered by the natural course of the infecting pathogen. However, the chance of COVID-19 reinfection are still not well established. This review aimed to discuss about reinfection-related studies, including causes and clinical manifestations, and reinfection management. Reinfection happens when a patient is infected by the SARS-CoV-2 virus, which has a different genome from previous infection. Although the comparison of clinical manifestation between reinfection and the previous infection is not clear, it is believed that vulnerable populations may have worse outcomes. Vaccination is the main option to reduce the severity of reinfection. Further studies are needed to understand the mechanisms and management of COVID-19 reinfection. Thus, the development of COVID-19 treatment and vaccine can be more effective .","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48978267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Luaran Hasil Leukemia Mieloid Akut yang Menjalani Terapi pada Ruang Kemoterapi Semi-Isolasi 半隔离化疗室治疗急性髓细胞白血病
Pub Date : 2022-10-01 DOI: 10.7454/jpdi.v9i3.857
Cosphiadi Irawan, Ricci Steven, Ralph Girson Gunarsa, Jeffry Beta Tenggara
Leukemia (LMA). Studi leukemia kesintasan pasien LMA yang diadmisi ruang rawat semi-isolasi. Studi kohort retrospektif menggunakan data sekunder rekam medis pasien yang terdiagnosis LMA pada Mochtar Riady Comprehensive Cancer Center ABSTRACT Introduction . Standard positive pressure isolation room is not yet widely available in Indonesia. In several private hospitals, current best practice is admitting patients to semi-isolation room with additional protective measures. Despite the limitation, this practice is considered safe and might benefit Acute Myeloid Leukemia (AML) patients. This study aimed to analyze the leukemic profile and survival in AML patients admitted to semi-isolation room. Methods . A retrospective cohort study was conducted using secondary data from medical record of AML patients diagnosed in Mochtar Riady Comprehensive Cancer Center between 2018 – 2020. Patients were divided into semi-isolation room group and not admitted to semi-isolation room group. Semi-isolation room patients who received standard chemotherapy regimen were further analyzed according to complication, outcome, and survival. Results. We included 45 AML patients, 53.3% were females, 42.2% in the 40-59 years age group, and 28.9% were AML-M2. Fifteen patients received standard chemotherapy regimen including D3A7, FLAG, ATRA-Daunorubicin-Cytarabine in semi-isolation room, 60% of them had complete remission after treatment completion. Patients who not admitted to semi-isolation room received conservative treatments including hydroxyurea, mercaptopurine, cytarabine cytoreduction, and decitabine. Among patients in semi-isolation room, 41.2% had sepsis and 29.4 % had septic shock, with most of the sources coming from bloodstream infection (80%), Acinetobacter baumannii remained the most prevalent microorganism. Treatment outcomes showed median Progression Free Survival (PFS) of 11 months, 1-year survival was 47%, and 2-year survival was 27%. Conclusions. In countries with limited standard isolation room, treatment of AML patients in semi-isolation room with infection control protocol could be considered in order to give the standard induction chemotherapy regimen. Although there was an infection risk, strict isolation policy produced good response (60% complete remission).
白血病(LMA)。白血病患者LMA半隔离治疗的研究。这项研究利用了Mochtar Riady癌症综合中心诊断LMA的医学研究数据摘要简介。标准的正压隔离室在印度尼西亚还没有普及。在几家私立医院,目前的最佳做法是将患者送入半隔离室,并采取额外的防护措施。尽管有局限性,但这种做法被认为是安全的,可能有益于急性髓细胞白血病(AML)患者。本研究旨在分析入住半隔离室的AML患者的白血病特征和生存率。方法。使用2018年至2020年间在Mochtar Riady综合癌症中心诊断的AML患者的医疗记录中的二次数据进行了一项回顾性队列研究。将患者分为半隔离室组和非隔离室组。根据并发症、结果和生存率,对接受标准化疗方案的半隔离室患者进行进一步分析。后果我们纳入了45名AML患者,53.3%为女性,42.2%为40-59岁年龄组,28.9%为AML-M2。15例患者在半隔离室接受标准化疗方案,包括D3A7、FLAG、ATRA柔红霉素-阿糖胞苷,其中60%的患者在治疗完成后完全缓解。未入住半隔离室的患者接受了保守治疗,包括羟基脲、巯基嘌呤、阿糖胞苷细胞减少和地西他滨。在半隔离室的患者中,41.2%的患者患有败血症,29.4%的患者患有感染性休克,其中大多数来源于血液感染(80%),鲍曼不动杆菌仍然是最常见的微生物。治疗结果显示,中位无进展生存期(PFS)为11个月,1年生存期为47%,2年生存率为27%。结论。在标准隔离室有限的国家,可以考虑在具有感染控制方案的半隔离室中治疗AML患者,以提供标准的诱导化疗方案。尽管存在感染风险,但严格的隔离政策产生了良好的反应(60%完全缓解)。
{"title":"Luaran Hasil Leukemia Mieloid Akut yang Menjalani Terapi pada Ruang Kemoterapi Semi-Isolasi","authors":"Cosphiadi Irawan, Ricci Steven, Ralph Girson Gunarsa, Jeffry Beta Tenggara","doi":"10.7454/jpdi.v9i3.857","DOIUrl":"https://doi.org/10.7454/jpdi.v9i3.857","url":null,"abstract":"Leukemia (LMA). Studi leukemia kesintasan pasien LMA yang diadmisi ruang rawat semi-isolasi. Studi kohort retrospektif menggunakan data sekunder rekam medis pasien yang terdiagnosis LMA pada Mochtar Riady Comprehensive Cancer Center ABSTRACT Introduction . Standard positive pressure isolation room is not yet widely available in Indonesia. In several private hospitals, current best practice is admitting patients to semi-isolation room with additional protective measures. Despite the limitation, this practice is considered safe and might benefit Acute Myeloid Leukemia (AML) patients. This study aimed to analyze the leukemic profile and survival in AML patients admitted to semi-isolation room. Methods . A retrospective cohort study was conducted using secondary data from medical record of AML patients diagnosed in Mochtar Riady Comprehensive Cancer Center between 2018 – 2020. Patients were divided into semi-isolation room group and not admitted to semi-isolation room group. Semi-isolation room patients who received standard chemotherapy regimen were further analyzed according to complication, outcome, and survival. Results. We included 45 AML patients, 53.3% were females, 42.2% in the 40-59 years age group, and 28.9% were AML-M2. Fifteen patients received standard chemotherapy regimen including D3A7, FLAG, ATRA-Daunorubicin-Cytarabine in semi-isolation room, 60% of them had complete remission after treatment completion. Patients who not admitted to semi-isolation room received conservative treatments including hydroxyurea, mercaptopurine, cytarabine cytoreduction, and decitabine. Among patients in semi-isolation room, 41.2% had sepsis and 29.4 % had septic shock, with most of the sources coming from bloodstream infection (80%), Acinetobacter baumannii remained the most prevalent microorganism. Treatment outcomes showed median Progression Free Survival (PFS) of 11 months, 1-year survival was 47%, and 2-year survival was 27%. Conclusions. In countries with limited standard isolation room, treatment of AML patients in semi-isolation room with infection control protocol could be considered in order to give the standard induction chemotherapy regimen. Although there was an infection risk, strict isolation policy produced good response (60% complete remission).","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43823632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sindroma Kasabach-Merritt pada Hemangioma Hati: Laporan Kasus 肝血管病Kasabach-Merritt综合症:病例报告
Pub Date : 2022-10-01 DOI: 10.7454/jpdi.v9i3.675
Michelle Frastica, Rudi Putranto, C. O. M. Jasirwan, Kresna Adhiatma
{"title":"Sindroma Kasabach-Merritt pada Hemangioma Hati: Laporan Kasus","authors":"Michelle Frastica, Rudi Putranto, C. O. M. Jasirwan, Kresna Adhiatma","doi":"10.7454/jpdi.v9i3.675","DOIUrl":"https://doi.org/10.7454/jpdi.v9i3.675","url":null,"abstract":"","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45262538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efektivitas Rotasi Opioid Dibandingkan Kombinasi Opioid untuk Mengobati Nyeri Kanker: Laporan Kasus Berbasis Bukti 阿片类药物旋转与阿片类药物混合治疗癌症疼痛的有效性:基于证据的案例报告
Pub Date : 2022-07-19 DOI: 10.7454/jpdi.v9i2.736
Edward Faisal, Shafira Puspadina, Rudi Putranto, Hamzah Shatri
Pain is the main symptom in cancer patients that needs to be addressed immediately because it can reduce the quality of life. Concern or the ineffectiveness of using one type of opioid makes it necessary for clinicians to understand how to rotate opioids. Therefore, this evidence-based case report was conducted to identify the effectiveness of opioid rotation and combined opioids for the cancer pain management through a literature search on three databases. Literature searching was performed by using Pubmed, Cochrane library, and EBSCO according to clinical inquiries. Of the 24 studies obtained, only one study met the criteria and was then critically assessed. The study found that pain score in both opioid rotation group (fentanyl transdermal) and combined opioids group (oral oxycodone and fentanyl transdermal) was decreased from 2.9 to 2.0 (p=0.22) and 3.0 to 1.8 (p<0.06), respectively. In addition, therapeutic success was achieved in 11 patients in the opioid rotation group and 12 patients in the combined opioids group (p=0.98). Based on the study, it can be concluded that opioid rotation is as effective as combined opioids in managing pain in cancer patients.
疼痛是癌症患者的主要症状,需要立即解决,因为它会降低生活质量。使用一种阿片类药物的担忧或无效性使临床医生有必要了解如何轮换阿片类。因此,本循证病例报告旨在通过对三个数据库的文献检索,确定阿片类药物轮换和联合阿片类治疗癌症疼痛管理的有效性。根据临床查询,使用Pubmed、Cochrane文库和EBSCO进行文献检索。在获得的24项研究中,只有一项研究符合标准,然后进行了严格评估。研究发现,阿片类药物轮换组(芬太尼透皮组)和联合阿片类物质组(口服羟考酮和芬太尼透皮)的疼痛评分分别从2.9降至2.0(p=0.22)和3.0降至1.8(p<0.06)。此外,阿片类药物轮换组的11名患者和阿片类联合用药组的12名患者获得了治疗成功(p=0.98)。根据该研究,可以得出结论,在癌症患者的疼痛管理中,阿片样药物轮换与阿片类联合用药一样有效。
{"title":"Efektivitas Rotasi Opioid Dibandingkan Kombinasi Opioid untuk Mengobati Nyeri Kanker: Laporan Kasus Berbasis Bukti","authors":"Edward Faisal, Shafira Puspadina, Rudi Putranto, Hamzah Shatri","doi":"10.7454/jpdi.v9i2.736","DOIUrl":"https://doi.org/10.7454/jpdi.v9i2.736","url":null,"abstract":"Pain is the main symptom in cancer patients that needs to be addressed immediately because it can reduce the quality of life. Concern or the ineffectiveness of using one type of opioid makes it necessary for clinicians to understand how to rotate opioids. Therefore, this evidence-based case report was conducted to identify the effectiveness of opioid rotation and combined opioids for the cancer pain management through a literature search on three databases. Literature searching was performed by using Pubmed, Cochrane library, and EBSCO according to clinical inquiries. Of the 24 studies obtained, only one study met the criteria and was then critically assessed. The study found that pain score in both opioid rotation group (fentanyl transdermal) and combined opioids group (oral oxycodone and fentanyl transdermal) was decreased from 2.9 to 2.0 (p=0.22) and 3.0 to 1.8 (p<0.06), respectively. In addition, therapeutic success was achieved in 11 patients in the opioid rotation group and 12 patients in the combined opioids group (p=0.98). Based on the study, it can be concluded that opioid rotation is as effective as combined opioids in managing pain in cancer patients.","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48325969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revaksinasi COVID-19 pada Kelompok Lansia dengan Frailty 在老年人群体中加入兄弟会
Pub Date : 2022-07-19 DOI: 10.7454/jpdi.v9i2.829
Ika Fitriana
Penelitian Vera, dkk. menunjukkan bahwa lanjut usia (lansia) merupakan kelompok yang memiliki mortalitas tinggi akibat Coronavirus disease (COVID-19) dan didominasi oleh kelompok frail. Lee, dkk. merekomendasikan penggunaan status frailty ini sebagai identifikasi faktor risiko yang bisa dimodifikasi pada kelompok lansia, yang dikaitkan dengan derajat beratnya COVID-19. Frailty dihubungkan dengan respons imunitas yang sudah menurun akibat kegagalan regulasi sistem homeostasis, akibatnya pasien frail rentan terhadap adanya stresor lingkungan dan luaran yang jelek.
维拉的研究,未知。表明老龄化是冠状病毒疾病(新冠肺炎)导致的高死亡率群体,并以弱势群体为主。李,dkk。建议将这种虚弱状态作为一种风险因素识别,可以在老年人中进行修改,与新冠肺炎的严重性相关。虚弱与由于未能调节体内平衡系统而导致的免疫反应下降有关,导致脆弱的患者容易受到环境和外部压力的影响。
{"title":"Revaksinasi COVID-19 pada Kelompok Lansia dengan Frailty","authors":"Ika Fitriana","doi":"10.7454/jpdi.v9i2.829","DOIUrl":"https://doi.org/10.7454/jpdi.v9i2.829","url":null,"abstract":"Penelitian Vera, dkk. menunjukkan bahwa lanjut usia (lansia) merupakan kelompok yang memiliki mortalitas tinggi akibat Coronavirus disease (COVID-19) dan didominasi oleh kelompok frail. Lee, dkk. merekomendasikan penggunaan status frailty ini sebagai identifikasi faktor risiko yang bisa dimodifikasi pada kelompok lansia, yang dikaitkan dengan derajat beratnya COVID-19. Frailty dihubungkan dengan respons imunitas yang sudah menurun akibat kegagalan regulasi sistem homeostasis, akibatnya pasien frail rentan terhadap adanya stresor lingkungan dan luaran yang jelek.","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43015339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infeksi SARS-CoV-2 dengan Komplikasi Perikarditis Akut bersamaan dengan Infeksi Malaria 急性心包并发症和疟疾感染
Pub Date : 2022-07-19 DOI: 10.7454/jpdi.v9i2.615
Kevin Hocin, Dinas Yudha Kusuma, Atit Puspitasari Dewi
Coronavirus disease 19 (COVID-19) can present as various symptoms, which range from asymptomatic to severe symptoms. We report a case of COVID-19 female patient with malaria co-infection who developed pericarditis complication. In this pandemic era, it is mandatory to rule out COVID-19. Coinfection with malaria will result in higher cytokine levels which lead to atypical complication , such as pericarditis. Prompt identification of atypical COVID-19 complications is essential as it can lower the mortality rate and reduce the duration of hospitalization.
冠状病毒病19 (COVID-19)可表现为各种症状,从无症状到严重症状不等。我们报告1例女性COVID-19合并疟疾感染并发心包炎的病例。在大流行时代,必须排除COVID-19。与疟疾合并感染将导致细胞因子水平升高,从而导致非典型并发症,如心包炎。及时发现COVID-19非典型并发症至关重要,因为这可以降低死亡率并缩短住院时间。
{"title":"Infeksi SARS-CoV-2 dengan Komplikasi Perikarditis Akut bersamaan dengan Infeksi Malaria","authors":"Kevin Hocin, Dinas Yudha Kusuma, Atit Puspitasari Dewi","doi":"10.7454/jpdi.v9i2.615","DOIUrl":"https://doi.org/10.7454/jpdi.v9i2.615","url":null,"abstract":"Coronavirus disease 19 (COVID-19) can present as various symptoms, which range from asymptomatic to severe symptoms. We report a case of COVID-19 female patient with malaria co-infection who developed pericarditis complication. In this pandemic era, it is mandatory to rule out COVID-19. Coinfection with malaria will result in higher cytokine levels which lead to atypical complication , such as pericarditis. Prompt identification of atypical COVID-19 complications is essential as it can lower the mortality rate and reduce the duration of hospitalization.","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43280117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Profil Klinis Pasien COVID-19 Lansia yang Dirawat Inap di RS Immanuel Bandung 新冠肺炎Lansia患者在伊曼纽尔·万隆医院接受Inap治疗的临床概况
Pub Date : 2022-07-19 DOI: 10.7454/jpdi.v9i2.743
Vera Vera, Yossie Guventri Eka Suprana
Introduction. It was reported that 11.2% out o f the 78,572 confirmed cases of COVID-19 in Indonesia was found in older people with a high mortality rate. There is no available data regarding functional and frailty status of these COVID-19 older patients. This study aimed to describe clinical profile of older COVID-19 patients in terms of geriatric aspect, in order to design better hospital policy for older patients in the COVID-19 isolation ward. Methods . This was a retrospective cohort study of confirmed COVID-19 patients aged >60 years which were admitted to Immanuel Teaching Hospital Bandung during the period of October 2020 - January 2021. C linical characteristic data, frailty status, mode of oxygen therapy , functional status (activity of daily living – ADL) during and after hospitalization, as well as patient hospitalization outcomes were recorded from the medical record. Results . There were 100 COVID-19 older patients, more than hal f were aged 60-70 years, most with not frail status. This study found that 74% of older patients had decreased ADL scores, once they got infected with COVID-19. We also found that 43% of COVID-19 older patients died during hospitalization, dominated by frail patients. Among COVID-19 older survivor , 55% had increased ADL score when discharged . A month later, only 25% patients had better ADL scores. Conclusion. Typical symptoms of COVID-19 are not always found in older patients. Apart from its deadly consequence and prolonged hospitalization, the impact of COVID-19 on older patients is decreased functional status, so special management policy for older COVID-19 patients should be considered.
介绍据报道,在印度尼西亚78572例新冠肺炎确诊病例中,11.2%是在死亡率高的老年人中发现的。关于这些新冠肺炎老年患者的功能和虚弱状态,没有可用的数据。本研究旨在从老年方面描述老年新冠肺炎患者的临床概况,以便为新冠肺炎隔离病房的老年患者设计更好的医院政策。方法。这是一项对2020年10月至2021年1月期间入住万隆伊曼纽尔教学医院的60岁以上确诊新冠肺炎患者的回顾性队列研究。从病历中记录患者的临床特征数据、虚弱状态、氧气治疗模式、住院期间和住院后的功能状态(日常生活活动能力)以及住院结果。后果有100名新冠肺炎老年患者,其中超过一半的患者年龄在60-70岁之间,大多数患者不虚弱。这项研究发现,74%的老年患者在感染新冠肺炎后,日常生活能力得分下降。我们还发现,43%的新冠肺炎老年患者在住院期间死亡,主要是虚弱的患者。在新冠肺炎老年幸存者中,55%的人出院时ADL评分升高。一个月后,只有25%的患者ADL评分更好。结论新冠肺炎的典型症状并不总是在老年患者中发现。除了致命的后果和延长的住院时间外,新冠肺炎对老年患者的影响是功能状态下降,因此应考虑对老年新冠肺炎患者的特殊管理政策。
{"title":"Profil Klinis Pasien COVID-19 Lansia yang Dirawat Inap di RS Immanuel Bandung","authors":"Vera Vera, Yossie Guventri Eka Suprana","doi":"10.7454/jpdi.v9i2.743","DOIUrl":"https://doi.org/10.7454/jpdi.v9i2.743","url":null,"abstract":"Introduction. It was reported that 11.2% out o f the 78,572 confirmed cases of COVID-19 in Indonesia was found in older people with a high mortality rate. There is no available data regarding functional and frailty status of these COVID-19 older patients. This study aimed to describe clinical profile of older COVID-19 patients in terms of geriatric aspect, in order to design better hospital policy for older patients in the COVID-19 isolation ward. Methods . This was a retrospective cohort study of confirmed COVID-19 patients aged >60 years which were admitted to Immanuel Teaching Hospital Bandung during the period of October 2020 - January 2021. C linical characteristic data, frailty status, mode of oxygen therapy , functional status (activity of daily living – ADL) during and after hospitalization, as well as patient hospitalization outcomes were recorded from the medical record. Results . There were 100 COVID-19 older patients, more than hal f were aged 60-70 years, most with not frail status. This study found that 74% of older patients had decreased ADL scores, once they got infected with COVID-19. We also found that 43% of COVID-19 older patients died during hospitalization, dominated by frail patients. Among COVID-19 older survivor , 55% had increased ADL score when discharged . A month later, only 25% patients had better ADL scores. Conclusion. Typical symptoms of COVID-19 are not always found in older patients. Apart from its deadly consequence and prolonged hospitalization, the impact of COVID-19 on older patients is decreased functional status, so special management policy for older COVID-19 patients should be considered.","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41375286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proporsi Gejala Depresi dan Hubungannya dengan Terapi ARV: Studi di Poliklinik VCT RSUP Dr. Kariadi 抑郁症症状的比例及其与抗逆转录病毒治疗的关系:在综合临床VCT RSUP中的研究Kariadi博士
Pub Date : 2022-07-19 DOI: 10.7454/jpdi.v9i2.745
M. Sofro, T. Raharja, Titis Hadiati, Linda Kartika Sari, Innawati Jusup
Introduction. Indonesia has the second largest HIV burden in Asia. The prevalence of depression in HIV/AIDS is 2-10 times higher than the general population, influenced by biological, environmental, psychological, and demographic factors. Data on the proportion of depression symptoms in HIV/AIDS patients and their relationship to biological factors are still limited, which needed for better treatment of HIV/AIDS. This study aimed to determine the prevalence of depression and its relationship to the biologic factors of ARV therapy (ART) in HIV/AIDS patients. Methods . Cross-sectional study was conducted among 142 HIV/AIDS patients undergoing ARV treatment at RSUP. Dr. Kariadi in January – March 2021. Demographic data, ART, ART type, side effects, ARV use duration, viral load, and CD4 cell count were obtained from medical records. The incidence of depression was assessed by the Beck Depression Inventory II (BDI-II). Results. The proportion of depression symptoms was 48.6%, consisting of mild depression (26.1%), moderate depression (17.6%), and severe depression (4.9%). Multivariate analysis resulted a significant relationship between the incidence of depression and biological factors, consisting of ART side effects, ART use duration, and CD4 cell count. Meanwhile, there was no significant relationship between the incidence of depression with the ART type and viral load. Conclusion. The proportion of depression symptoms in HIV patients undergoing ART is 48.6%. It is concluded that biological factors can affect the proportion of depression in patients with ART.
介绍印度尼西亚是亚洲第二大艾滋病毒感染国。受生物、环境、心理和人口因素的影响,艾滋病患者的抑郁症患病率是普通人群的2-10倍。关于艾滋病毒/艾滋病患者抑郁症状的比例及其与生物学因素的关系的数据仍然有限,这对于更好地治疗艾滋病毒/艾滋病是必要的。本研究旨在确定HIV/AIDS患者抑郁的患病率及其与抗逆转录病毒治疗(ART)生物学因素的关系。方法。对142名在RSUP接受ARV治疗的HIV/AIDS患者进行了横断面研究。Kariadi博士,2021年1-3月。从医疗记录中获得人口统计学数据、抗逆转录病毒疗法、抗逆转录疫苗类型、副作用、抗逆转录药物使用持续时间、病毒载量和CD4细胞计数。抑郁症的发生率通过Beck抑郁量表II(BDI-II)进行评估。后果抑郁症症状的比例为48.6%,包括轻度抑郁症(26.1%)、中度抑郁症(17.6%)和重度抑郁症(4.9%)。多因素分析显示,抑郁症的发生率与生物学因素之间存在显著关系,包括ART副作用、ART使用时间和CD4细胞计数。同时,抑郁症的发病率和ART类型和病毒载量之间没有显著关系。结论接受抗逆转录病毒治疗的HIV患者中抑郁症状的比例为48.6%。因此,生物学因素会影响抗逆转录病毒疗法患者的抑郁比例。
{"title":"Proporsi Gejala Depresi dan Hubungannya dengan Terapi ARV: Studi di Poliklinik VCT RSUP Dr. Kariadi","authors":"M. Sofro, T. Raharja, Titis Hadiati, Linda Kartika Sari, Innawati Jusup","doi":"10.7454/jpdi.v9i2.745","DOIUrl":"https://doi.org/10.7454/jpdi.v9i2.745","url":null,"abstract":"Introduction. Indonesia has the second largest HIV burden in Asia. The prevalence of depression in HIV/AIDS is 2-10 times higher than the general population, influenced by biological, environmental, psychological, and demographic factors. Data on the proportion of depression symptoms in HIV/AIDS patients and their relationship to biological factors are still limited, which needed for better treatment of HIV/AIDS. This study aimed to determine the prevalence of depression and its relationship to the biologic factors of ARV therapy (ART) in HIV/AIDS patients. Methods . Cross-sectional study was conducted among 142 HIV/AIDS patients undergoing ARV treatment at RSUP. Dr. Kariadi in January – March 2021. Demographic data, ART, ART type, side effects, ARV use duration, viral load, and CD4 cell count were obtained from medical records. The incidence of depression was assessed by the Beck Depression Inventory II (BDI-II). Results. The proportion of depression symptoms was 48.6%, consisting of mild depression (26.1%), moderate depression (17.6%), and severe depression (4.9%). Multivariate analysis resulted a significant relationship between the incidence of depression and biological factors, consisting of ART side effects, ART use duration, and CD4 cell count. Meanwhile, there was no significant relationship between the incidence of depression with the ART type and viral load. Conclusion. The proportion of depression symptoms in HIV patients undergoing ART is 48.6%. It is concluded that biological factors can affect the proportion of depression in patients with ART.","PeriodicalId":32700,"journal":{"name":"Jurnal Penyakit Dalam Indonesia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43460190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jurnal Penyakit Dalam Indonesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1